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SBackground: The TNM staging system for esophageal cancer in the seventh edition of the AJCC Cancer Stag-
ing Manual incorporates tumor grade and location for staging pT2-3N0M0 esophageal squamous cell carci-
noma. Patients with pT2N0M0, classified as stage IIA according to the sixth edition of the AJCC Cancer
Staging Manual, can now be classified as stage IB, IIA, or IIB. We discuss whether these changes lead to a better
prediction of the prognosis of these patients and aimed to find out other factors to forecast patient prognosis.
Methods: We retrospectively analyzed 317 patients with postoperative pathologic stage T2N0M0 who under-
went esophagectomy between 1990 and 2005 at Sun Yat-sen University Cancer Center.We performed univariate
and multivariate analyses to identify prognostic factors for survival and used the Kaplan–Meier method to dem-
onstrate the prognostic efficacy of each prognostic factor, including tumor grade and location.
Results: The 5-year overall survival was 57%, with a median survival of 84.5 months (6.94 years). Univariate
analysis indicated that age, alcohol consumption, and tumor grade were associated with survival. Multivariate
Cox proportional hazard regression analysis revealed that alcohol consumption and tumor grade were indepen-
dent prognostic factors. Survival analysis using the Kaplan–Meier method demonstrated age, cigarette smoking,
alcohol consumption, tumor grade, and location as prognostic factors.
Conclusions: For pT2N0M0 esophageal squamous cell carcinoma, the seventh edition of the AJCC Cancer
Staging Manual does not provide a more distinguishable prediction of prognosis compared with the sixth
edition. Tumor grade is an independent prognostic factor in patients with pT2N0M0 esophageal squamous
cell carcinoma, whereas tumor location is not. Furthermore, alcohol consumption is an independent prognostic
factor that may imply a worse prognosis. (J Thorac Cardiovasc Surg 2013;146:45-51)Esophageal squamous cell carcinoma (ESCC) has a poor
prognosis and is one of the most common and aggressive
cancers found throughout Asia, especially in China.1,2
Surgery is the main treatment, but the overall survival
remains unsatisfactory. Half of those patients had
potentially curative resections with a 3.5-year survival of
41.3%; for those resected for palliation, the 3.5-year survival
was 7.3%. The overall survival remains at 20% to 25%.3
Accurate cancer staging is important for formulation of
treatment protocols, therapeutic evaluations, and assess-
ment of prognosis. In addition, it allows for treatment com-
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The Journal of Thoracic and Cthe AJCC Cancer Staging Manual was released in 2010,4
updating the TNM staging system for esophageal cancer.
In this manual, tumor location is simplified and includes
the esophagogastric junction and proximal 5 cm of the
stomach. Furthermore, T classifications are redefined and
T4 is subclassified. Regional lymph nodes are redefined,
and N is subclassified according to the number of regional
metastatic lymph nodes. M is redefined, and stages are
separated for squamous cell carcinoma and adenocarci-
noma. Stages are reassigned using the T, N, M, and G
classifications.4
T2N0M0 ESCC was previously classified as stage IIA
according to the sixth edition of the AJCC Cancer Staging
Manual,5 but it can now be classified as stage IB, IIA, and
IIB according to the seventh edition. We retrospectively
analyzed 317 patients with T2N0M0 ESCC who underwent
esophagectomy to investigate whether the new stage classi-
fication meant varied prognosis and whether any other
factors affected survival.PATIENTS AND METHODS
Patient Data Acquisition
This study was approved by the Sun Yat-sen University Cancer Center
Hospital Ethics Committee. All patients who underwent esophagectomy
for esophageal cancer at the Thoracic Surgery Department of Sun Yat-sun
University Cancer Center from 1990 to 2005 were reviewed. Amongardiovascular Surgery c Volume 146, Number 1 45
Abbreviation and Acronym
ESCC ¼ esophageal squamous cell carcinoma
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Sthem, 317who had pT2N0M0ESCC and underwent curative (R0) resection
were included in this study. All tumors were located in the thoracic seg-
ments, and no patient received neoadjuvant chemotherapy or radiotherapy.
Clinical Data
The study included 317 patients with T2N0M0 ESCC (222 male and 95
female) and a median age of 56 years (mean age, 55.6 years; standard
deviation, 9.774) who underwent esophagectomy between 1990 and
2005. Of these, 186 patients (58.7%) smoked cigarettes and 60 patients
(18.9%) consumed alcohol (a drinker refers to those who drink>100 g/d
for>1 year.). In regard to tumor location, 40 (12.7%) were in the upper
thoracic region, 218 (69.0%) were in the middle thoracic region, and 58
(18.4%) were in the lower thoracic region. According to tumor grade,
121 (38.3%) were well differentiated (G1), 126 (39.9%) were moderately
differentiated (G2), and 69 (21.8%) were poorly differentiated (G3). The
1-, 3-, and 5-year overall survivals were 75%, 63%, and 57%, respectively,
with a median survival of 84.5 months (6.94 years). Patient characteristics
are summarized in Table 1.
Tumor Location
In this study, the medical records were accomplished before the publi-
cation of the seventh edition of the AJCC Cancer Staging Manual,4 so the
relationship between the exact location of tumor and the new landmarks
was not recorded. However, the distance from the tumor to the superior
incisor has been measured by endoscopy and recorded in detail, and thus
can be used to estimate the location of tumor. A tumor 15 to 20 cm away
from the superior incisor was considered as cervical, whereas tumors 20
to 25 cm, 25 to 30 cm, and 30 to 40 cm were considered upper thoracic,
middle thoracic, and lower thoracic, respectively.
Statistical Analysis
All potential and reported prognostic factors, including demographic
data, cigarette smoking, and alcohol consumption; operative information;
and tumor characteristics were analyzed. Patient data were evaluated
according to pathologic stage classification of the sixth edition of the
AJCC Cancer Staging Manual.5 Cervical, upper thoracic, middle thoracic,
and lower thoracic were coded as 1, 2, 3, and 4, respectively, when tumor
location was involved in the analysis. In terms of differentiation grade,
tumors that were highly, intermediately, and poorly differentiated were
coded as 1, 2, and 3, respectively.
Follow-up
Postoperative patients were followed regularly at our outpatient depart-
ment every 3months in the first 2 years after operation, every 6months in the
third year, and once per year in the following 2 years. Outpatient department
visits encompassed history taking, physical examination, chest x-ray, bar-
ium meal, abdominal type B ultrasonography, and tumor biomarkers, in-
cluding squamous cell carcinoma and carcinoembryonic antigen.
Endoscopic examination and computed tomographywere carried out on oc-
casion. Patients with survival time more than 5 years were contacted by our
follow-up department via telephone ormail. Overall survival was defined as
the time from operation to death or the last follow-up. The last follow-up
checkpoint was April 2010. Fourteen of 317 patients were lost to follow-up.
Statistics
Overall survival was calculated on the basis of survival time from oper-
ation to death or the last follow-up. Life table analysis was used to calculate46 The Journal of Thoracic and Cardiovascular Surgethe 1-, 3-, and 5-year overall survival. Univariate analysis and multivariate
Cox proportional hazard regression analysis were used to identify potential
prognostic factors. Potential prognostic factors associated with survival
probability that had a significance level of P less than .10 were considered
in multivariable Cox proportional hazard regression analysis. Patient
survival curves were constructed using the Kaplan–Meier method. The
log-rank test was used to compare survival differences between groups
for each variable. All statistical calculations were performed using the
Statistical Package for the Social Sciences version 17.0 (IBM SPSS Inc,
Chicago, Ill).RESULTS
New Criteria for Staging
The 317 patients with pT2N0M0 ESCCwere divided into
3 subgroups, namely, IB, IIA, and IIB, according to the sev-
enth edition of the AJCCCancer StagingManual.4 Kaplan–
Meier analysis revealed no significant differences between
the survival curves for each group. P value calculated by
the log-rank test was .305, which indicated that the 3 sub-
groups resulting from the new criteria did not have a signif-
icantly different prognosis. The seventh edition did not
provide a more distinguishable prediction of patients with
pT2N0M0 ESCC (Figure 1).Prognostic Factors
Prognostic factors affecting long-term survival are evalu-
ated in Tables 2 and 3. Univariate analysis indicated that age
(P ¼ .038), alcohol consumption (P ¼ .035), and tumor
grade (P ¼ .007) were significantly associated with patient
survival. Likewise, multivariate Cox proportional hazard
regression analysis indicated that alcohol consumption
(P ¼ .015) and tumor grade (P ¼ .011) were significantly
associated with patient survival (Table 3).
The Kaplan–Meier method and log-rank test were used to
construct survival curves for age, alcohol consumption, and
cigarette smoking. The cutoff point for age was defined at
the median age of 56 years. However, age as a continuous
variable was not dichotomized elsewhere. Age (P ¼ .029),
alcohol consumption (P ¼ .028), and cigarette smoking
(P ¼ .039) were observed to be significantly associated
with patient survival (Table 3). Furthermore, advanced
age, cigarette smoking, and alcohol consumption were asso-
ciated with worse prognosis (Figure 2).Role of Tumor Grade and Location in Esophageal
Squamous Cell Carcinoma
Univariate analysis and multivariable Cox proportional
hazard regression analysis indicated that tumor grade was
associated with patient survival (P¼ .007 and P¼ .011, re-
spectively) (Tables 1 and 2). We also established the sur-
vival curves using the Kaplan–Meier method, which
indicated that well-differentiated tumors had better progno-
sis (Figure 3). For tumor location, to exclude the effect of
tumor grade, we also established the survival curves of dif-
ferent tumor location in each grade. For moderately andry c July 2013
TABLE 1. Baseline characteristics of patients
Variables No. (%) or median
Age, y 56
Gender
Male 222 (70.0%)
Female 95 (30.0%)
Cigarette smoking
Yes 186 (58.7%)
No 131 (41.3%)
Alcohol consumption
Yes 60 (18.9%)
No 257 (81.1%)
Family history of cancer
Yes 26 (8.2%)
No 291 (91.8%)
Surgical approach
Left thoracic 249 (78.5%)
Right thoracic 68 (21.5%)
Tumor location
Upper thoracic 40 (12.7%)
Middle thoracic 218 (69.0%)
Lower thoracic 58 (18.4%)
Tumor grade
Well differentiated (G1) 121 (38.3%)
Moderately differentiated (G2) 126 (39.9%)
Poorly differentiated (G3) 69 (21.8%)
TABLE 2. Possible prognostic factors and relative risks
Possible prognostic factor P HR 95% CI
Gender .606 1.187 0.619-2.273
Age .038 1.023 1.001-1.045
Cigarette smoking .263 1.360 0.794-2.329
Alcohol consumption .035 1.570 1.032-2.389
Family history of cancer .343 0.716 0.359-1.428
VC .389 0.732 0.361-1.487
MVV .267 1.009 0.993-1.026
FEV1 .956 1.024 0.434-2.420
FEV1% .619 1.007 0.979-1.035
Blood loss .725 1.000 0.999-1.001
3-FL .223 0.647 0.322-1.302
Length of tumor .372 1.043 0.951-1.143
Depth of tumor invasion .516 1.131 0.780-1.639
Tumor grade .007 1.373 1.091-1.728
Tumor location .463 0.881 0.628-1.235
Postoperative anastomotic leakage .379 1.381 0.673-2.835
Surgical approach .215 1.461 0.802-2.661
No. of removed LNs .938 0.999 0.969-1.030
HR, Hazard ratio; CI, confidence interval; VC, vital capacity; MVV, maximal volun-
tary ventilation; FEV1, forced expiratory volume in 1 second; FEV1%, forced
expiratory volume in 1 s expressed as percent predicted; 3-FL, 3-field lymphadenec-
tomy; LN, lymph node.
Situ et al General Thoracic Surgery
G
T
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not associated with patient survival (P¼ .714 and P¼ .227,
respectively) (Figure 4). For the well-differentiated tumor,FIGURE 1. Kaplan–Meier survival curves for patients staged by the sev-
enth edition of the AJCC Cancer Staging Manual.4 Survival differences
were analyzed using Cox regression analysis.
The Journal of Thoracic and Ctumor location was linked with patient survival
(P ¼ .006) (Figure 4). Although the Kaplan–Meier method
showed that tumor location was significantly associated
with patient survival (P ¼ .015), it was not identified as
an independent prognostic factor in multivariable Cox
proportional hazard regression analysis.DISCUSSION
The seventh edition of the AJCC Cancer Staging Man-
ual4 adopts evidence from evidence-based medicine and
a new statistical model. For this revision, inputs from Asian
scholars were invited because Asian countries have a higher
incidence of ESCC, accounting for one third of patients
with ESCC. The seventh edition incorporates tumor grade
and location; however, these factors are less significant
than TNM, which generally affects only the stage classifica-
tion of patients with pT2-3N0M0. The new staging system
specifically defines anatomic segmentation of esophageal
cancer, considering the survival influence of organs adja-
cent to the tumors.
In the seventh edition of the AJCC Cancer Staging Man-
ual,4 tumor location is redefined as the length between the
upper incisor and the upper edge of the tumor, not the tumor
center. The esophagus is now divided into cervical, upper
thoracic, middle thoracic, and lower thoracic regions by 3
new landmarks, namely, the thoracic entrance, inferior bor-
der of azygos vein arch, and inferior border of inferior
pulmonary vein.
In this study, the 5-year overall survival was 57%, which
was in accordance with the data previously reported.ardiovascular Surgery c Volume 146, Number 1 47
TABLE 3. Survival differences after multivariate Cox proportional hazard regression analysis
Demographics Patient, no. Univariate log-rank P Multivariate regression P HR 95% CI
Alcohol consumption .028 .015 1.627 1.101-2.405
Yes 62
No 240
Age (y) .029
<56 60
56 238
Cigarette smoking .039
Yes 186
No 131
Tumor location .015
Upper thoracic 40
Middle thoracic 218
Lower thoracic 58
Tumor grade .015 .011 1.323 1.066-1.641
Well differentiated (G1) 121
Moderately differentiated (G2) 126
Poorly differentiated (G3) 69
HR, Hazard ratio; CI, confidence interval.
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SKillinger and colleagues6 reported their experience with
pathologic T2N0M0 disease treated using esophagectomy
alone. In this retrospective analysis, the survival of patients
with pT2N0M0 disease was on par with that of patients with
pT1N0M0 (50% at 5 years; P ¼ .83) and trended toward
improved survival over patients with pT3N0M0 disease
(P ¼ .06). Tachibana and colleagues7 published the results
of their study on patients with pT1 and pT2 ESCC who un-
derwent esophagectomy. Among patients who were node
negative, those with pT1 and pT2 tumors had similar
cancer-specific survival. Rice and colleagues8 reported
that 31 patients with pT2N0M0 ESCC who underwent
surgery first had a 5-year overall survival of 61%  9.3%.
We performed a survival analysis for 317 patients with
pT2N0M0 ESCC. Univariate analysis showed that age,
alcohol consumption, and tumor grade were associated
with patient survival. Furthermore, multivariable Cox pro-
portional hazard regression analysis revealed that alcohol
consumption and tumor grade were independent prognostic
factors. Cigarette smoking was found to be associated with
patient survival using the Kaplan–Meier method.
The prognostic role of age has been demonstrated in
many previous studies. It has been confirmed that advanced
age is associated with worse prognosis. Elsayed and col-
leagues9 reported that increasing age was a significant risk
factor for mortality and survival after esophagectomy. The
mortality was particularly high when associated with a pre-
operative cardiac or respiratory morbidity. Eloubeidi and
colleagues10 showed that across all stages, age was an im-
portant predictor of survival in patients with esophageal
carcinoma.
In regard to alcohol consumption, the predictive role on
survival varies among studies. Kountourakis and
colleagues11 demonstrated that alcohol consumption48 The Journal of Thoracic and Cardiovascular Surgeinfluences the long-term outcome of patients with
cT2N0M0 esophageal cancer, although different opinions
exist.12 In our study, alcohol consumption was found to
be strongly associated with poor survival.
Because cigarette smoking and alcohol consumption syn-
ergistically contribute to ESCC development,13-15 we
evaluated smoking as a prognostic factor. Survival curves
demonstrated that smoking is not only a risk factor for
ESCC development but also a prognostic factor in
patients already diagnosed with ESCC. Identical results
were reported by Khan and colleagues16 in a cohort from
the Kashmir Valley, India. Kountourakis and colleagues11
showed that smoking influenced long-term outcome in
patients with cT2N0M0 esophageal cancer, a conclusion
confirmed by Shitara and colleagues.17
Univariate analysis, multivariate Cox proportional haz-
ard regression analysis, and the Kaplan–Meier method
showed that tumor grade had a significant influence on sur-
vival of patients with pT2N0M0 ESCC and was an indepen-
dent prognostic factor, whereas tumor location was not.
Tumor grade was shown to be a prognostic indicator in
perijunctional esophagogastric carcinoma long before the
adoption of the new staging system18 and was incorporated
in the new staging system19; however, its role in ESCC
remains unclear.10,20,21 In a 292-patient study, Li and col-
leagues2 showed that tumor grade was a prognostic factor
in univariate analysis, but not in multivariate Cox regression
analysis. Roder and colleagues22 reported that in squamous
cell carcinoma–predominant databases, tumor differentia-
tion was not significantly associated with survival.
Similar conflicting results have been obtained for tumor
location.2,10,20 Although studies have shown that tumors
in the lower segment of esophagus had better prognosis
because of the increased sufficiency of resection, thesery c July 2013
FIGURE 2. Kaplan–Meier survival curves for patients stratified by age
(A), alcohol consumption (B), and cigarette smoking (C). Survival differ-
ences were analyzed using Cox regression analysis.
FIGURE 3. Kaplan–Meier survival curves for patients stratified by tumor
grade (A) and location (B). Survival differences were analyzed using Cox
regression model analysis.
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adenocarcinoma of the distal intra-abdominal esophagus;
therefore, the results may not reflect the exact effect of tu-
mor location on thoracic ESCC prognosis.10,19 To study
this issue further, Doki and colleagues23 analyzed 501 pa-
tients with thoracic esophageal cancer (92% with ESCC).
They reported that upper, middle, and lower thoracic esoph-
ageal cancers had similar 5-year disease-free survival, but
the mode of tumor recurrence differed for each primary tu-
mor location. We believe the fact that all of these patients
with T2N0M0 had tumors that were contained within the
wall of the esophagus may account for our results. T3 or
higher tumors located in the lower chest are likely more
amenable to wide resection with better margins than thoseardiovascular Surgery c Volume 146, Number 1 49
FIGURE 4. Kaplan–Meier survival curves for patients with well (A),
moderately (B), and poorly (C) differentiated tumor stratified by
tumor location. UT, Upper thoracic; MT, middle thoracic; LT, lower
thoracic.
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Slocated in the upper chest. In this regard, tumor location is
probably less important with T2N0M0 tumors.
However, none of these studies focused solely on patients
with pT2N0M0 ESCC, the main group affected by the new
G stage classification. In our study, we found that tumor
grade was an independent prognostic factor, and a relatively
poorer differentiation was associated with poor survival.
Different tumor locations were associated with survival,
but they may not be independent prognostic factors. This
may be attributed to the impaired accuracy of tumor loca-
tion during the conversion from the sixth5 to the seventh
edition4 of the AJCC Cancer Staging Manual.
CONCLUSIONS
In addition to well-characterized factors affecting sur-
vival of patients with esophageal carcinoma, we showed
that alcohol consumption and tumor grade were important
prognostic factors for patient survival. Tumor grade was
a strong prognostic factor in patient survival, as indicated
in the seventh edition of the AJCC Cancer Staging Man-
ual,4 whereas tumor location was not. The revised TNM
staging system does not suggest a more efficient prediction
of prognosis than the previous edition for patients with
pT2N0M0 ESCC.
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